The aim of this study was to prospectively study the safety, functional outcomes and complications of all patients undergoing bilateral single-stage sequential (BSSS) unicompartmental knee arthroplasty (UKA) in our unit. 394 cemented UKAs were performed in this unit between 2006–2010. A retrospective review identified 38 patients (76 knees) who underwent BSSS UKA, performed by a single surgeon. Patient demographics were recorded as well as pre and post-operative Oxford knee scores, tourniquet times, time to mobilisation, length of in-patient stay and any complications. There were 22 women and 16 men with a mean age of 64. The mean duration of follow-up was 30 months. The mean total tourniquet time was 83 minutes. The mean time to mobilisation was 18 hours and the average length of stay was 3.5 days. This compares favourably with an institutional average length of stay of two days for a single UKA. There was a significant improvement in the mean pre- to post-operative Oxford Knee Score (from 14 to 34, p< 0.0001). One patient required operative fixation of a tibial plateau fracture after sustaining a mechanical fall two months following surgery. There were no other major complications, including thrombo-embolic events or deep infections. Two patients required excision of a superficial suture granuloma.Purpose of the study
Methods and results
31 patients, between the ages of 59 and 74 years, were referred to one onrthopaedic consultant as trochanteric bursitis. All were females. Of these 7 patients were diagnosed as osteoarthritis of the hip or underwent further investigations for spinal conditions. 24 patients were clinically diagnosed as trochanteric bursitis. All these patients had ultrasound examination of the hips by a radiologist with a special interest in musculoskeletal diseases. Except for one patient the rest had either gluteus medius inflammation or tears with or without involvement of gluteus minimus. All these patients with positive findings had 80mg of depomedrone injection under USG guidance. At 6 weeks follow up 21 had complete relief of symptoms. 4 had recurrence of symptoms at 3 months when they had another dose of depomedrone und USG guidance. At one year 18 were free of symptoms and the 3 with some recurrence of symptoms did not want any intervention.
